Developing of primers for amplification of pathogenic variants associated with breast cancer
DOI:
https://doi.org/10.32480/rscp.2024.29.2.3742Keywords:
breast cancer, primers, genetic variantsAbstract
Between 5-10% of cases of breast cancer (BC) are attributed to hereditary genetic mutations. The BCRA 1 and BCRA 2 genes present variants associated with BC with high prevalence and penetrance. The prevalence of these variants differs according to the populations studied, depending on factors such as ethnicity and geographic distribution. Objective: To develop assays for the amplification of regions that have been reported as carriers of genetic variants associated with breast cancer in regional studies. Target regions were selected, primers were designed using the Primer3 tool, PCR amplification of the regions was performed using genomic DNA extracted from a randomly chosen volunteer patient’s whole blood and the amplified fragments were checked on agarose gels. Two primers were designed to amplify regions containing three variants observed in Paraguayan descent women and other countries that may be represented in the Itapuense population: c.5351_5352insA; c.5681_5682insA and c.4035delA. The results of the PCR amplification using the designed primers gave fragments of the expected sizes. The primers designed in this study will allow the evaluation of three variants found in women of Paraguayan descent in Latin American studies.
Downloads
References
1.Organización Mundial de la Salud. Cáncer de mama. 2023. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/breast-cancer
2.Infobae. Cáncer de mama: El riesgo de la falta de controles en la más jóvenes [Internet]. Buenos Aires: Sociedad Argentina de Mastología; 2021. Disponible en: https://www.samas.org.ar/index.php/blog-infosam/420-cancer-de-mama-en-pandemia-el-riesgo-de-la-falta-de-controles-en-las-mas-jovenes
3.Organización Panamericana de la Salud. Cáncer. 2022. Disponible en: https://www.paho.org/es/temas/cancer#:~:text=Los%20tipos%20de%20c%C3%A1ncer%20diagnosticados%20con%20mayor%20frecuencia%20en%20las,uterino%20(6%2C4%20%25)
4.Dirección de Vigilancia de Enfermedades no Transmisibles. Más de 1.700 pacientes diagnosticados con cáncer mamario en el 2019. Asunción: Ministerio de Salud Pública y Bienestar Social; 2020. Disponible en: https://dvent.mspbs.gov.py/mas-de-1-700-pacientes-diagnosticados-con-cancer-mamario-en-el-2019/#:~:text=Datos%20parciales%20revelan%20que%20la,de%20mama%2C%20durante%20ese%20a%C3%B1o
5.Fernández TA, Reigosa YA. Cáncer de mama hereditario. Comunidad y Salud. 2016;14(1):52-60. Disponible en: https://ve.scielo.org/scielo.php?pid=S1690-32932016000100008&script=sci_abstract
6.Narod S, Rodríguez A. Predisposición genética para el cáncer de mama: genes BRCA1 y BRCA2. Salud Pública de México. 2011;53(5). Disponible en: https://www.scielosp.org/pdf/spm/v53n5/a10v53n5.pdf
7.Easton D, Ford D, Bishop D. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995;56(1):265-71. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7825587/#:~:text=Under%20the%20assumption%20of%20no,CI%208%25%2D47%25).
8.Landrum M, Chitipiralla S, Brown G, Chen C, Gu B, Hart J, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48(D1):D835-D845. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31777943/
9.Jara JH, Genc B, Stanford M, Pytel P, Roos R, Weintraub S, et al. Evidence for an early innate immune response in the motor cortex of ALS. Journal of Neuroinflammation. 2017;14(1). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485686/
10.Instituto Nacional del Cáncer. Mutaciones en el gen BRCA: el riesgo de cáncer y las pruebas genéticas. EEUU: NIH; 2020. Disponible en: https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica/hoja-informativa-brca
11.National Librery of Medicine. GenBank Overview. Rockville, EEUU: NIH; 2022. Disponible en: https://www.ncbi.nlm.nih.gov/genbank/
12.National Library of Medicine. ClinVar. Rockville, EEUU: NIH; 2022. Disponible en: https://www.ncbi.nlm.nih.gov/clinvar/
13.Cerretini R, Mercado G, Morganstein J, Schiaffi J, Reynoso M, Montoya D, et al. Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina. Breast Cancer Res Treat. 2019;178:629-636. Disponible en: http://link.springer.com/10.1007/s10549-019-05411-9
14.Martínez J, Muñoz M, Corriols Molina M, Silva Arrechavala J. Mutaciones genéticas asociadas a cáncer de mama hereditario en mujeres nicaragüenses. Revista Torreón Universitario. 2021;10(29). Disponible en: http://portal.amelica.org/ameli/jatsRepo/387/3872515007/3872515007.pdf
15.Chavarri-Guerra Y, Blazer K, Weitzel J. Genetic Cancer Risk Assessment for Breast Cancer in Latin America. Rev Invest Clin. 2017;69(2):94-102. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28453507/
16.Da Costa E Silva Carvalho S, Cury NM, Brotto DB, De Araujo LF, Alves Rosa RC, Texeira LA, et al. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC Med Genomics. 2020;13(1):21. Disponible en: https://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-019-0652-y
17.Valle AD, Acevedo C, Esperón P, Neffa F, Artagaveytia N, Santander G, et al. Cáncer de mama y ovario hereditario en Uruguay: resultados del screening para mutaciones en genes de susceptibilidad por secuenciación de nueva generación. Revista Médica del Uruguay. 2017;33(2):102-107. Disponible en: https://revista.rmu.org.uy/index.php/rmu/article/view/112
18.Buleje J, Guevara-Fujita M, Acosta O, Huaman FDP, Danos P, Murillo A, et al. Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer. Mol Genet Genomic Med. 2017;5(5):481-494. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/mgg3.301
19.Solano AR, Aceto GM, Delettieres D, Veschi S, Neuman MI, Alonso E, et al. BRCA1 and BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin. SpringerPlus. 2012;1:20. Disponible en: https://springerplus.springeropen.com/articles/10.1186/2193-1801-1-20
20.Jara L, Morales S, De Mayo T, Gonzalez-Hormazabal P, Carrasco V, Godoy R. Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations. Biological Research. 2017;50(1):35. Disponible en: http://biolres.biomedcentral.com/articles/10.1186/s40659-017-0139-2
21.Tan O, Shrestha M, Cunich M, Schofield DJ. Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness. Clinical Genetics. 2018;93(3):533-544. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/cge.13199
22.Primer3 web. Primer3 web version 4.1.0. Disponible en: https://primer3.ut.ee/
23.Promega. Wizard® Genomic DNA Purification Kit Technical Manual. Promega; 2023. Disponible en: https://worldwide.promega.com/resources/protocols/technical-manuals/0/wizard-genomic-dna-purification-kit-protocol/
24. Software informer. BioEdit 7.7. Software informer; 2022. Disponible en: https://bioedit.software.informer.com/
25.Adaniel C, Salinas F, Donaire J, Bravo M, Peralta O, Paredes H, et al. Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer. J Glob Oncol. 2019; 5:1-14. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31125277/
26.Zayas-Villanueva OA, Campos-Acevedo LD, Lugo-Trampe JDJ, Hernández-Barajas D, González-Guerrero JF, Noriega-Iriondo MF, et al. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study. BMC Cáncer. 2019;19(1):722. Disponible en: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5950-4
27.Rubio S, Pacheco-Orozco RA, Gómez AM, Perdomo S, García-Robles R. Secuenciación de nueva generación (Ngs) de ADN: presente y futuro en la práctica clínica. Univ Med. 2020;61(2). Disponible en: https://revistas.javeriana.edu.co/index.php/vnimedica/article/view/27461
28.SantaLucia J. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci USA. 1998;95(4):1460-1465. Disponible en: https://pnas.org/doi/full/10.1073/pnas.95.4.1460
29.Syamsidi A, Aanisah N, Fiqram R, Jultri IA. Primer design and analysis for detection of meca gene. J Trop Pharm Chem. 2021;5(3):245-253. Disponible en: https://www.researchgate.net/publication/353001074_Primer_Design_and_Analysis_for_Detection_of_mecA_gene
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista de la Sociedad Científica del Paraguay
This work is licensed under a Creative Commons Attribution 4.0 International License.
El/los autores autorizan a la Revista de la Sociedad Científica del Paraguay a publicar y difundir el articulo del cual son autores, por los medios que considere apropiado.
